Inhibitory effect of bombesin/gastrin-releasing peptide (GRP) antagonists RC-3950-II and RC-3095 on MCF-7 MIII human breast cancer xenografts in nude mice.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0753-3322(94)90007-8PMID 7858155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi.

  2009cited by this paper
• Determination of subcutaneous tumor size in athymic (nude) mice

  2004cited by this paper
• Inhibition of growth of MKN45 human gastric‐carcinoma xenografts in nude mice by treatment with bombesin/gastrin‐releasing‐peptide antagonist (RC‐3095) and somatostatin analogue RC‐160

  1994cited by this paper
• Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.

  1994cited by this paper
• Inhibitory effect of bombesin/gastrin‐releasing peptide antagonist RC‐3095 and luteinizing hormone—releasing hormone antagonist SB‐75 on the growth of MCF‐7 MIII human breast cancer xenografts in athymic nude mice

  1994cited by this paper
• Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors

  1994cited by this paper
• Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro.

  1994cited by this paper
• Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice.

  1993cited by this paper
• Effect of bombesin, gastrin‐releasing peptide (GRP)(14–27) and bombesin/GRP receptor antagonist RC‐3095 on growth of nitrosamine‐induced pancreatic cancers in hamsters

  1993cited by this paper
• Use of radioreceptor assay and cell superfusion system for in vitro screening of analogs of growth hormone-releasing hormone.

  1993cited by this paper
• Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo.

  1992cited by this paper
• Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines.

  1992cited by this paper
• Cancer statistics, 1992

  1992cited by this paper
• Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095.

  1992cited by this paper
• Inhibition of growth of PC‐82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC‐3095 or combination of agonist [D‐Trp6]‐luteinizing hormone‐releasing hormone and somatostatin analog RC‐160

  1992cited by this paper
• Gastrin releasing peptide GRP(14–27) in human breast cancer cells and in small cell lung cancer

  1991cited by this paper
• Decrease in the AgNOR number in Dunning R3327 prostate cancers after treatment with an agonist and antagonist of luteinizing hormone-releasing hormone.

  1991cited by this paper
• [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.

  1991cited by this paper
• Mastoparan, a novel mitogen for Swiss 3T3 cells, stimulates pertussis toxin-sensitive arachidonic acid release without inositol phosphate accumulation

  1991cited by this paper
• [Psi13,14] Bombesin Analogues Inhibit Growth of Small Cell Lung Cancer in Vitro and in Vivo

  1991cited by this paper
• Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.

  1991cited by this paper
• Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls.

  1991cited by this paper
• Modulation of inositol lipid hydrolysis in human breast cancer cells by two classes of bombesin antagonist.

  1991cited by this paper
• Bombesin stimulates proliferation of human breast cancer cells in culture.

  1991cited by this paper
• Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095).

  1991cited by this paper
• Multiple synergistic signal transduction pathways regulate c-fos expression in Swiss 3T3 cells: the role of cyclic AMP.

  1990cited by this paper
• Activation of inositol phospholipid signaling and Ca2+ efflux in human breast cancer cells by bombesin.

  1990cited by this paper
• Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro.

  1990cited by this paper
• Bombesin stimulation of c-fos expression and mitogenesis in Swiss 3T3 cells: the role of prostaglandin E2-mediated cyclic AMP accumulation.

  1990cited by this paper
• Characterization, in some human breast cancer cell lines, of gastrin‐releasing peptide‐like receptors which are absent in normal breast epithelial cells

  1990cited by this paper
• Arachidonic acid release by bombesin. A novel postreceptor target for heterologous mitogenic desensitization.

  1990cited by this paper
• Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas.

  1989cited by this paper
• The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer.

  1989cited by this paper
• Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.

  1989cited by this paper
• Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer.

  1989cited by this paper
• Gastrin-releasing peptide-, calcitonin gene-related peptide-, and calcitonin-like immunoreactivity in human breast cyst fluid and gastrin-releasing peptide-like immunoreactivity in human breast carcinoma cell lines.

  1989cited by this paper
• Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease.

  1988cited by this paper
• Early signals underlying the induction of the c-fos and c-myc genes in quiescent fibroblasts: studies with bombesin and other growth factors.

  1988cited by this paper
• Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer.

  1987cited by this paper
• Thioridazine enhances lysosomal accumulation of epidermal growth factor and toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin.

  1986cited by this paper
• Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. II. Changes in Na+ and Ca2+ fluxes, Na+/K+ pump activity, and intracellular pH

  1986cited by this paper
• Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

  1985cited by this paper
• Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

  1985cited by this paper
• Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen.

  1985cited by this paper
• Current concepts: Biological actions of bombesin related peptidesI. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer

  1985cited by this paper
• Bombesin, neurotensin and pro-gamma-melanotropin immunoreactants in human milk.

  1985cited by this paper
• Bombesin, neurotensin and pro-γ-melanotropin immunoreactants in human milk

  1985cited by this paper
• Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells.

  1984cited by this paper
• A bombesin immunoreactive peptide in milk.

  1984cited by this paper
• Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.

  1984cited by this paper
• Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells.

  1983cited by this paper
• Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor.

  1983cited by this paper
• Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture.

  1982cited by this paper
• Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice.

  1981cited by this paper
• Epidermal growth factor stimulation of human breast cancer cells in culture.

  1980cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• CANCER OF THE BREAST

  1941cited by this paper

• Synthesis and Evaluation of Novel 68Ga-Labeled GRPR-Targeted PET Tracers Derived from [d-Phe6,Pro14]Bombesin(6-14) and [d-Phe6,des-Met14]Bombesin(6-14) Sequences.

  2026cites this paper
• GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma

  2024cites this paper
• 68Ga-Labeled [Thz14]Bombesin(7–14) Analogs: Promising GRPR-Targeting Agonist PET Tracers with Low Pancreas Uptake

  2023cites this paper
• 68Ga-Labeled [Leu13ψThz14]Bombesin(7–14) Derivatives: Promising GRPR-Targeting PET Tracers with Low Pancreas Uptake

  2022cites this paper
• Dual Anti-cancer and Anti-Itch Activity of PD176252 Analogues: Design, Synthesis and Biological Evaluation.

  2019cites this paper
• Positron Emission Tomography Imaging of the Gastrin-Releasing Peptide Receptor with a Novel Bombesin Analogue

  2019cites this paper
• GPCR Modulation in Breast Cancer

  2018cites this paper
• Gastrin-Releasing Peptide Receptor Targeting in Cancer Treatment: Emerging Signaling Networks and Therapeutic Applications.

  2016cites this paper
• A new near-infrared absorption and fluorescent probe based on bombesin for molecular imaging

  2009cites this paper
• Development of a radioimmunoassay for a pseudononapeptide bombesin/GRP antagonist with antitumor activity.

  2009cites this paper
• Potential-dependent characterization of bombesin adsorbed states on roughened Ag, Au, and Cu electrode surfaces at physiological pH.

  2009cites this paper
• Bombesin-modified 6-14 C-terminal fragments adsorption on silver surfaces: influence of a surface substrate.

  2008cites this paper
• Gastrin-releasing peptide and cancer.

  2006cites this paper
• A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies

  2006cites this paper
• OBSERVAÇÕES PRELIMINARES SOBRE A FARMACOCINÉTICA E A FARMACODINÂMICA DO RC-3095 - UM NOVO ANTAGONISTA DA BOMBESINA/FATOR DE LIBERAÇÃO DA GASTRINA, EM PACIENTES PORTADORES DE NEOPLASIAS SÓLIDAS AVANÇADAS

  2006cites this paper
• Effect of a cytotoxic analog of LH-RH (T-98) on the growth of estrogendependent MXT mouse mammary cancers: Correlations between growth characteristics and EGF receptor content of tumors

  2005cites this paper
• Gastrin-releasing peptide (GRP) induces angiogenesis and the specific GRP blocker 77427 inhibits tumor growth in vitro and in vivo

  2005cites this paper
• Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix.

  2001cites this paper
• Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumour imaging?

  2001cites this paper
• Hypothalamic hormones and cancer.

  2001cites this paper
• Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists

  2000cites this paper
• Inhibition of growth of MDA‐MB‐468 estrogen‐independent human breast carcinoma by bombesin/gastrin‐releasing peptide antagonists RC‐3095 and RC‐3940‐II

  2000cites this paper
• Gastrointestinal Hormones and Gastrointestinal Cancer Growth

  1999cites this paper
• Gastrointestinal Endocrinology

  1999cites this paper
• The Ewing tumor family of peripheral primitive neuroectodermal tumors expresses human gastrin-releasing peptide.

  1998cites this paper
• Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095.

  1998cites this paper
• A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers.

  1997cites this paper
• Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.

  1997cites this paper
• Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.

  1997cites this paper
• Pharmacological profiles of two bombesin analogues in cells transfected with human neuromedin B receptors.

  1996cites this paper
• Correlation between the effects of bombesin antagonists on cell proliferation and intracellular calcium concentration in Swiss 3T3 and HT-29 cell lines.

  1996cites this paper
• New antagonists of bombesin gastrin-releasing Peptide with C-terminal leu-psi-(ch2n)tac-nh2.

  1995cites this paper
• New pseudononapeptide bombesin antagonists with C-terminal leu-psi(ch2n)tac-nh2 show high binding-affinity to bombesin/grp receptors on cfpac-1 human pancreatic-cancer cells.

  1995cites this paper
• Antagonists of bombesin/gastrin‐releasing peptide inhibit growth of SW‐1990 human pancreatic adenocarcinoma and production of cyclic AMP

  1995cites this paper